Mineralys Therapeutics Statistics
NASDAQ: MLYSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.66-0.50 (-3.53%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Mineralys Therapeutics by the numbers
Mineralys Therapeutics has a market capitalization of $1.21 billion based on 88.56M shares outstanding. With trailing EPS of $-4.30, Mineralys Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.3% below its 50-day average and 46.9% below its 200-day average.
Average daily trading volume is 1.55M shares, or about $21.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MLYS valuation vs. peer median
| Metric | MLYS | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.21B | $1.23B | -2% |
| Avg. volume | 1.55M | 1.82M | -15% |
Peer median across 8 companies: AMPH, GHRS, OCUL, GENB, SLN, MNKD, OPK, LBRX.
Valuation
- Market cap
- $1.21B
- EPS (TTM)
- $-4.30
- Shares outstanding
- 88.56M
Price and trading
- Previous close
- 14.16
- Open
- 13.81
- Day range
- 13.57 – 14.79
- 52-week range
- 13.57 – 44.13
- 52-week change
- -67.38%
- Beta
- —
- Volume
- 1.35M
- Average volume
- 1.55M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.21B
- Forward Pe
- -5.63
- Eps
- -4.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 44.13
- Week52 Low
- 13.57
- Avg Volume
- 1.55M
- Shares Outstanding
- 88.56M
- Ma50
- 21.12
- Ma200
- 25.75
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -69.05%
- Pct From52w Low
- 0.66%